International Journal of Medical and Pharmaceutical Research
2021, Volume-2, Issue-1 doi: 10.5281/zenodo.8052500
Original Article
A Brief Study On Ginseng (Panax Ginseng)
 ,
 ,
Abstract
Ginseng has been around since prehistory. Shennong, also known as Emperor Yan, the Yellow Emperor, or one of the "Three Emperors" (the Emperor who is supposed to have founded herbal medicine some 5,500 years ago), is said to have tasted hundreds of plants in order to discover many medicinal herbs in China. For thousands of years, humans have used diverse plants as nutrients, beverages, cosmetics, dyes, and medicines to maintain health and improve quality of life. Panax ginseng C.A. Meyer is regarded the most valuable plant among herbs, particularly in Asia, and ginseng has been in the spotlight globally. Even in the Western world, where modern research facilities and highly qualified man-power are accessible and are thought to be capable of curing any difficult-to-cure condition, many people have recently been reported to use herbal medicine, particularly ginseng. Many scientists contributed papers on "Chemopreventive effects of ginseng" to the current collection of papers. I categorised this collection as follows to help readers grasp it better and easier: The spiritual aspect of ginseng in the Far East, the history of ginseng, ginseng nomenclature and geographical distribution, and the various ginseng products.
Recommended Articles
Loading Image...
Volume-2, Issue-1
Citations
425 Views
80 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved